Methods for administering long-lasting hypoglycemic agents
A technology of incretin and plasma, which is applied in the field of administering long-acting hypoglycemic drugs, and can solve the problem that therapeutic treatment of diabetes is not feasible
Inactive Publication Date: 2009-08-26
SMITHKLINE BECKMAN CORP
3 Cites 0 Cited by
AI-Extracted Technical Summary
Problems solved by technology
View more
Abstract
The present invention relates to methods and pharmaceutical compositions relating to administering hypoglycemic agents and/or GLP-1 agonists wherein the mean maximum plasma concentration (Cmax) and/or Area Under the Curve (AUC) values of the hypoglycemic agent are increased and/or sustained.
Application Domain
Peptide/protein ingredientsGlucagons
Technology Topic
DrugLong lasting +3
Image
Examples
- Experimental program(5)
Example Embodiment
Example Embodiment
Example Embodiment
PUM


Description & Claims & Application Information
We can also present the details of the Description, Claims and Application information to help users get a comprehensive understanding of the technical details of the patent, such as background art, summary of invention, brief description of drawings, description of embodiments, and other original content. On the other hand, users can also determine the specific scope of protection of the technology through the list of claims; as well as understand the changes in the life cycle of the technology with the presentation of the patent timeline. Login to view more.